By Vijay Kumar Malesu Reviewed by Susha Cheriyedath, M.Sc. Jun 25 2026 Scientists say gut microbes may do more than recycle estrogen, but turning the endocrine-microbiome axis into a cancer therapy target will require stronger causal and clinical evidence. Review: Beyond estrobolome 1.0: unraveling endocrine-microbiome axis as a driver and therapeutic target in hormone-driven cancers . Image Credit: Explode / Shutterstock In a recent review published in the journal  npj Biofilms and Microbiomes